References
- Hayes D F, Kaplan W. Evaluation of patients after primary therapy. Diseases of the Breast, J R Harris, M E Lippman, M Morrow, S Hellman. J B Lippincolt Co, Philadelphia 1996; 629–647
- Coleman R E, Rubens R D. The clinical course of bone metastases from breast cancer. Br J Cancer 1987; 55: 61–66
- Clark G M, Sledge G W, Jr, Osbome C K, et al. Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients. J Clin Oncol 1987; 5: 55–61
- Goldhirsch A, Gelber R D, Castiglione M. Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: patterns and prognoses. J Clin Oncol 1988; 6: 89–97
- Coleman R E, Rubens R D. Bone metastases and breast cancer. Cancer Treat Rep 1985; 12: 251–270
- Hayward J L, Rubens R D, Carbone P P, et al. Assessment of response to therapy in advanced breast cancer. Br J Cancer 1977; 35: 292–298
- Johnson C C, Smelled C AW, Melon L J. Clinical use of bone densitometry. N Eng J Med 1992; 324: 1105–1109
- Mazess R, Collick B, Trempe J, et al. Performance evaluation of a dual-energy x-ray hone densitometer. Calcif Tissue Int 1989; 44: 228–232
- Kelly T I, Slovik D M, Schoenfeld D A, et al. Quantitative digital radiography versus dual photon absorptiometry of the lumbar spine. J Clin Endocrinol Metab 1988; 67: 839–844
- Gliier C C, Steiger P, Selvidge R, et al. Comparative assessment of dual-photon absorptiometry and dual-energy radiography. Radiology 1990; 174: 223–228
- Wahner H W, Dunn W L, Brown M L, et al. Comparison of dual-energy x-ray absorptiometry and dual photon absorptiometry for bone mineral absorptiometry for bone mineral measurements of the lumbar spine. Mayo Clin Proc 1988; 63: 1075–1084
- Slosman D O, Casez J P, Pichard C, et al. Assessment of whole-body composition with dual-energy x-ray absorptiometry. Radiology 1992; 185: 593–598
- El-Hajj Fuleihan G, Testa M, Angell J E, et al. Reproducibility of DXA absorptiometry: a model for bone loss estimates. J Bone Miner Res 1995; 10: 1004–1014
- Roberston D D, Mintzer C M, Weissman B N, et al. Distal loss of bone following total knee athroplasty. J Bone Joint Surg 1994; 76A: 68–76
- Muindi J, Coombes R C, Golding S, et al. The role of computed tomography in the detection of bone metastases in breast cancer patients. Br J Radiol 1983; 56: 233–236
- Bellamy E A, Nicholas D, Ward M, et al. Comparison of computed tomography and conventional radiology in the assessment of treatment response of lytic bony metastases in patients with carcinoma of the breast. Clin Radiol 1987; 38: 351–355
- Crone-Munzebrock W, Carl U M. Dual-energy CT-scan quantification of recalcification in ostolyses of the vertebral body due to mammary carcinoma in the course of antineoplastic treatment. Clin Exp Metab 1990; 8: 173–179
- Janicek M J, Hayes D F, Kaplan W D. Healing flare in skeletal metastases from breast cancer. Radiology 1994; 192: 201–204
- Vogel C L, Schoenfelder J, Shemano I, et al. Worsening bone scan in the evaluation of antitumor response during hormonal therapy of breast cancer. J Clin Oncol 1995; 13: 1123–1129
- Mariette X, Khalifa P, Ravaud P, et al. Bone densitometry in patients with multiple myeloma. Am J Med 1992; 93: 595–598
- Kamby C, Vejborg I, Daugaard S, et al. Clinical and radiologic characteristics of bone metastases in breast cancer. Cancer 1987; 60: 2524–2531
- Twining P, Williams M R, Moms A H, et al. The use of the pelvic radiograph to assess therapeutic response in bone metastases from breast cancer. Clin Radiol 1988; 39: 583–585
- Libslutz H I. Hortobagyi GN Radiographic evaluation of therapeutic response in bony metastases of breast cancer. Skeletal Radiol 1981; 7: 159–165
- Coombes R C, Dady P, Parsons C, et al. Assessment of response of bone metastases to systemic treatment in patients with breast cancer. Cancer 1983; 52: 610–614
- Scheid V, Buzdar A U, Smith T L, et al. Clinical course of breast cancer patients with osseous metastasis treated with combination chemotherapy. Cancer 1986; 58: 2589–2593
- Richelson L S, Wahner H W, Melton L J, III, et al. Relative contributions of aging and estrogen deficiency to postmenopausal bone loss. N Engl J Med 1984; 311: 1273–1275
- Riggs B L, Melton L J, III. Involutional osteoporosis. N Engl J Med 1986; 326: 1676–1686
- Powles T J, Hickish T, Kanis J A, et al. The effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women. J Clin Oncol. 1996; 14: 78–84